USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS

The present invention is directed towards the method of potentiating the anti-growth effects of type I interferon (IFN) on cells in a target cell population comprising increasing the number of functional IFNAR2c receptors on the surface of modifiedcells within the target cell population and then exp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: VOGEL, DAVID, RUSSELL-HARDE, DEAN, CROZE, ED
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator VOGEL, DAVID
RUSSELL-HARDE, DEAN
CROZE, ED
description The present invention is directed towards the method of potentiating the anti-growth effects of type I interferon (IFN) on cells in a target cell population comprising increasing the number of functional IFNAR2c receptors on the surface of modifiedcells within the target cell population and then exposing the modified cells to a therapeuttically effective amount of a type I IFN or by exposure to endogenously produced IFN.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_LT2003016A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>LT2003016A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_LT2003016A3</originalsourceid><addsrcrecordid>eNqFjEEKwjAQRbtxIeoZnAsUYgvuQ5yYQJkJyYh0VUqJq6KFen8sxYU7V58H_71tMd4SAlsQh-BJMFqMTBDRYBCOUA0QuGnDQv6CYJz2BMKA5DQZXD1N4str5Ls4QGvRSFqTiwX-p5r2xebRj3M-fHdXHC2KcWWeXl2ep37Iz_zuGqmUqtXprOv_jw8AmzWo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS</title><source>esp@cenet</source><creator>VOGEL, DAVID ; RUSSELL-HARDE, DEAN ; CROZE, ED</creator><creatorcontrib>VOGEL, DAVID ; RUSSELL-HARDE, DEAN ; CROZE, ED</creatorcontrib><description>The present invention is directed towards the method of potentiating the anti-growth effects of type I interferon (IFN) on cells in a target cell population comprising increasing the number of functional IFNAR2c receptors on the surface of modifiedcells within the target cell population and then exposing the modified cells to a therapeuttically effective amount of a type I IFN or by exposure to endogenously produced IFN.</description><edition>7</edition><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20031027&amp;DB=EPODOC&amp;CC=LT&amp;NR=2003016A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20031027&amp;DB=EPODOC&amp;CC=LT&amp;NR=2003016A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VOGEL, DAVID</creatorcontrib><creatorcontrib>RUSSELL-HARDE, DEAN</creatorcontrib><creatorcontrib>CROZE, ED</creatorcontrib><title>USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS</title><description>The present invention is directed towards the method of potentiating the anti-growth effects of type I interferon (IFN) on cells in a target cell population comprising increasing the number of functional IFNAR2c receptors on the surface of modifiedcells within the target cell population and then exposing the modified cells to a therapeuttically effective amount of a type I IFN or by exposure to endogenously produced IFN.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjEEKwjAQRbtxIeoZnAsUYgvuQ5yYQJkJyYh0VUqJq6KFen8sxYU7V58H_71tMd4SAlsQh-BJMFqMTBDRYBCOUA0QuGnDQv6CYJz2BMKA5DQZXD1N4str5Ls4QGvRSFqTiwX-p5r2xebRj3M-fHdXHC2KcWWeXl2ep37Iz_zuGqmUqtXprOv_jw8AmzWo</recordid><startdate>20031027</startdate><enddate>20031027</enddate><creator>VOGEL, DAVID</creator><creator>RUSSELL-HARDE, DEAN</creator><creator>CROZE, ED</creator><scope>EVB</scope></search><sort><creationdate>20031027</creationdate><title>USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS</title><author>VOGEL, DAVID ; RUSSELL-HARDE, DEAN ; CROZE, ED</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_LT2003016A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>VOGEL, DAVID</creatorcontrib><creatorcontrib>RUSSELL-HARDE, DEAN</creatorcontrib><creatorcontrib>CROZE, ED</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VOGEL, DAVID</au><au>RUSSELL-HARDE, DEAN</au><au>CROZE, ED</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS</title><date>2003-10-27</date><risdate>2003</risdate><abstract>The present invention is directed towards the method of potentiating the anti-growth effects of type I interferon (IFN) on cells in a target cell population comprising increasing the number of functional IFNAR2c receptors on the surface of modifiedcells within the target cell population and then exposing the modified cells to a therapeuttically effective amount of a type I IFN or by exposure to endogenously produced IFN.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_LT2003016A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T22%3A36%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VOGEL,%20DAVID&rft.date=2003-10-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ELT2003016A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true